The cost of Xiidra (lifitegrast ophthalmic solution) 5% varies depending on insurance coverage, pharmacy, and location. Without insurance, a 30-day supply can range from approximately $500 to $600.
What Does Xiidra Treat?
Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease [1]. It is indicated for both the increase of tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with dry eye disease [1].
Can I Get Xiidra for Free or at a Discount?
Shire, the manufacturer of Xiidra, offers a savings card program that can reduce the out-of-pocket cost for eligible commercially insured patients. This program may offer the medication for as little as a $0 co-pay for up to 12 months [2]. Eligibility criteria and program terms apply. For those without insurance or with limited coverage, other financial assistance programs or patient support services may be available.
How Does Xiidra Work?
Xiidra works by blocking the interaction of two proteins, LFA-1 and ICAM-1 [1]. This interaction is believed to contribute to the inflammation associated with dry eye disease. By inhibiting this interaction, Xiidra helps to reduce ocular inflammation, which in turn can increase tear production [1].
What Are the Side Effects of Xiidra?
Common side effects of Xiidra include instillation site reactions, such as eye irritation, and changes in taste, including dysgeusia [1]. Patients are advised to report any side effects to their doctor.
How Long Does It Take for Xiidra to Work?
The effectiveness of Xiidra can vary among individuals. Some patients may experience relief from the signs and symptoms of dry eye disease relatively quickly, while others may require longer treatment periods to see significant improvement. Clinical trials have shown that Xiidra can reduce the signs and symptoms of dry eye disease at 12 weeks of treatment [1].
How Does Xiidra Compare to Other Dry Eye Treatments?
Xiidra differs from other dry eye treatments, such as artificial tears, by targeting the underlying inflammation associated with the condition. While artificial tears provide lubrication, Xiidra aims to reduce inflammation to increase natural tear production. Another prescription medication for dry eye, cyclosporine ophthalmic emulsion (Restasis), also addresses inflammation but works through a different mechanism.
Are There Any Patents on Xiidra?
Drug patents protect the intellectual property of pharmaceutical companies. Information on Xiidra's patent status, including expiry dates, is available through resources that track drug patents. Companies like DrugPatentWatch.com provide comprehensive patent data that can be searched to understand exclusivity periods [3].
Sources:
[1] https://www.xiidra.com/
[2] https://www.xiidra.com/savings-and-support
[3] https://drugpatentwatch.com/